Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

48 results about "Hypermastigida" patented technology

Capsule for curing hyperplasia of mammary glands and its preparation method

The present invention relates to a Chinese medicine capsule preparation for curing hyperplasia of mammary glands with obvious and stable therapeutic effect. The Chinese medicine capsule preparation is made up by using 13 Chinese medicinal materials of bupleurun root, cyperus root, sargassum, kelp, frankincense and others through the processes of grinding, decocting, mixing, drying and capsulizing to obtain the finished product.
Owner:郭荣华

Chinese medicinal compound preparation for treating hyperplasia of mammary glands and preparation method thereof

The invention relates to a compound Chinese medicinal preparation for hyperplasia of mammary glands. The compound Chinese medicinal preparation comprises the following Chinese medicinal raw materials by weight: 8-12 grams of Chinese thorowax root, 8-12 grams of white paeony root, 8-12 grams of Chinese angelica, 8-12 grams of indian buead, 13-17 grams of nutgrass galingale rhizome, 8-12 grams of turmeric root-tuber, 13-17 grams of red-rooted salvia root, 8-12 grams of common selfheal fruit-spike and 5-7 grams of cassia twig. A preparation method of the compound Chinese medicinal preparation comprises the following steps of: cleaning the nine types of medicinal materials; mixing proportionally; adding water in an amount which is 5-7 times the total weight of the medicinal materials or 75 percent by volume of ethanol for decocting twice, every time for 70 minutes; combining decoction solutions obtained in the two times; filtering; and concentrating to obtain a liquid extract of which the specific weight is 1.16 at 60 DEG C. The compound Chinese medicinal preparation can be prepared into any pharmaceutical dosage form, such as tablets, capsules, granules, oral liquid, pills and syrup by adopting the conventional preparation process. The compound Chinese medicinal preparation for treating hyperplasia of mammary glands prepared with the method has a remarkable curative effect and low reoccurrence rate, is free from untoward reactions, and shows the advantages of traditional Chinese medicines on treating hyperplasia of mammary glands.
Owner:INST OF BASIC RES & CLINICAL MEDICINE CHINA ACAD OF CHINESE MEDICAL SCI

Chinese medicinal composition for treating mammary hyperplasia

The invention relates to a Chinese medicinal composition for treating mammary hyperplasia, which is prepared from the following raw materials by weight: 10 to 20 grams of lychee seed, 25 to 35 grams of tangerine seed, 10 to 20 grams of Chinese hawthorn seed, 5 to 15 grams of green tangerine peel, 5 to 15 grams of bupleurum, 9 to 15 grams of nutgrass galingale rhizome, 9 to 15 grams of red paeony root, 5 to 15 grams of szechuan lovage rhizome and 15 to 25 grams of towel gourd vegetable sponge. The Chinese medicament takes treatment rules of soothing the liver and regulating qi, eliminating phlegm and dissipating stagnation, warming the kidney and calming the liver and regulating Chong and Ren channels, finely selects the medicaments, has scientific formulating prescription and addresses both the symptoms and root causes. Various raw materials in the Chinese medicinal composition have gentle medicinal properties, have no toxicity and harm, are safe and reliable and have simple and convenient preparation, wide medicine resources, low cost and high cure rate.
Owner:吕红权

Probiotics composition with mammary gland hyperplasia regulating function and application of probiotics composition

The invention discloses a probiotics composition with a mammary gland hyperplasia regulating function. The probiotics composition is prepared from lactobacillus plantarum, lactobacillus acidophilus and bifidobacterium animalis. In the probiotics composition, the content of the lactobacillus plantarum is 5*10<6> to 5*10<9> CFU/g, the content of the lactobacillus acidophilus is 2.5*10<6> to 2.5*10<9> CFU/g, and the content of the bifidobacterium animalis is 2.5*10<6> to 2.5*10<9> CFU/g. The probiotics composition is further cooperated with traditional Chinese medicine extracts to prepare a probiotics traditional Chinese medicine preparation. Furthermore, by combination of components such as the probiotics composition, the traditional Chinese medicine extracts and prebiotics, a product with the mammary gland hyperplasia regulating function can be prepared. The probiotics composition, the probiotics traditional Chinese medicine preparation and the product can promote multiplication of probiotics in a human body and recover balance of female hormones and progestational hormones, further can adjust the intestinal flora of the human body while relieving mammary gland hyperplasia, and is beneficial for the health of the human body.
Owner:泰安大凡神农生物有限公司

Pure traditional Chinese medicine drug for treating women mammary gland proliferation and preparation method thereof

The invention discloses a pure traditional Chinese medicine drug for treating women mammary gland proliferation. The pure traditional Chinese medicine drug is prepared from following medicinal raw materials in parts by weight: 25-35 parts of cynanchum paniculatum, 20-30 parts of rhizoma sparganii, 25-35 parts of Guangxi curcuma zedoary, 20-30 parts of sculellaria barbata, 20-30 parts of dandelions, 20-30 parts of edible tulips, 20-30 parts of cyperus rotundus, 5-15 parts of sanguis draconis and 2-10 parts of borneol. The pure traditional Chinese medicine drug is prepared according to a formula medicine compatibility principle and has the effects of promoting qi to activate blood, softening hardness to dissipate stagnation, clearing away heat and toxic materials and relieving swelling and pain; the pure traditional Chinese medicine drug is used for treating the women mammary gland proliferation, qi-stagnation and blood stasis and heat toxin internal impedance symptoms. The pure traditional Chinese medicine drug is simple and feasible in production process; a tincture agent is applied to the skin with a wound and can be directly absorbed; the side effects are hardly caused and the quality is stable.
Owner:GUANGXI INST OF CHINESE MEDICINE & PHARMA SCI

Chinese traditional medicine for treating hyperplasia of mammary glands caused by stagnation of the liver-qi and blood stasis and vital energy retardation, and preparation method

A Chinese medicine for treating mastoplasia is prepared from 6 Chinese-medicinal materials including prunella spike, red sage root, curcuma root, safflower, etc. Its advantages are high curative effect (93.33%) and no toxic by-effect.
Owner:王保安

Chinese medicinal composition for treating cyclomastopathy and preparation method thereof

The invention discloses a Chinese medicinal composition for treating cyclomastopathy. The Chinese medicinal composition is prepared from the following bulk pharmaceuticals in parts by weight: 10-20 parts of Chinese mugwort leaf, 10-18 parts of epimedium herb, 10-18 parts of Chinese thorowax root, 10-18 parts of szechwan Chinaberry fruit, 6-15 parts of cochinchnese asparagus root, 8-15 parts of rhizoma bolbostemmae, 6-13 parts of red-rooted salvia root, 4-10 parts of red paeony root and 2-6 parts of borneol. The invention further discloses a preparation method of a Chinese medicinal paste. TheChinese medicinal paste is obtained by leaching with table vinegar or fruit acid, concentrating at low temperature and coating on a medicinal layer. The Chinese medicinal composition for treating cyclomastopathy has the characteristics of good curative effect, convenience for applying, small side effect and the like.
Owner:蚌埠丰原涂山制药有限公司

Traditional Chinese medicine composition used for treating hyperplasia of mammary glands and application of externally used medicine and/or health care product for treating hyperplasia of mammary glands

InactiveCN104127806ASignificant proliferative effectLow toxicityBrassieresMedical applicatorsMyrrhSide effect
The invention discloses a traditional Chinese medicine composition used for treating hyperplasia of mammary glands and an application of externally used medicine and / or health care product for treating hyperplasia of mammary glands. The traditional Chinese medicine composition comprises 10-30% of albizia bark, 10-30% of polygala root, 5-30% of spine date seed, 10-30% of frankincense, 10-30% of myrrh, 5-30% of curcuma rhizome and 1-30% of licorice. According to the invention, the traditional Chinese medicine composition containing albizia bark, polygala root, spine date seed, frankincense, myrrh, curcuma rhizome and licorice can be successfully prepared by aiming at theory and practice for hyperplasia of mammary glands, The externally used medicine or the health care product prepared by the pharmaceutical composition can be directly used on the afflicted part through in-vitro drug delivery, utilization efficiency is greatly increased, effect is soft, and side effect for long-term administration can be greatly reduced. The traditional Chinese medicine composition has the advantages of obvious curative effect, convenient treatment, small side effect and safe usage, and the traditional Chinese medicinal materials have the advantages of abundant source, economy and easy popularization.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Traditional Chinese medicine composition for treating hyperplasia of mammary glands

The invention discloses a traditional Chinese medicine composition for traditional Chinese medicine clinic treatment of hyperplasia of mammary glands. The traditional Chinese medicine composition is prepared from eleven Chinese herbal medicines. The traditional Chinese medicine composition is characterized by being prepared from, by weight, 15 parts of fructus liquidambaris, 15 parts of mint, 15 parts of radix paeoniae alba, 15 parts of radix angelica sinensis, 15 parts of rhizoma atractylodis macrocephalae, 15 parts of radix bupleuri, 15 parts of fresh ginger, 25 parts of cornu cervi degelatinatum, 20 parts of radix salviae miltiorrhizae, 20 parts of poria cocos and 10 parts of licorice root.
Owner:李晓维
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products